D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 28.15%977.99M | 29.71%933.04M | 28.84%3.19B | 31.32%884.86M | 30.04%827.17M | 27.02%763.13M | 26.49%719.35M | 12.35%2.48B | 13.55%673.82M | 21.41%636.09M |
Cost of revenue | 21.19%334.52M | 22.76%319.81M | 17.11%1.12B | 10.59%296.65M | 11.29%289.67M | 31.07%276.03M | 18.58%260.51M | 1.55%958.81M | 0.97%268.25M | 14.86%260.28M |
Gross profit | 32.10%643.47M | 33.65%613.23M | 36.24%2.07B | 45.03%588.21M | 43.03%537.51M | 24.83%487.1M | 31.47%458.85M | 20.42%1.52B | 23.74%405.58M | 26.39%375.8M |
Operating expense | 44.78%848.66M | 16.02%755.53M | -5.58%2.51B | -16.22%665.53M | -11.66%611.36M | -4.90%586.18M | 16.26%651.21M | 57.04%2.66B | 71.68%794.38M | 80.26%692.03M |
Operating profit | -107.09%-205.19M | 26.02%-142.31M | 61.25%-442.61M | 80.11%-77.32M | 76.64%-73.86M | 56.19%-99.08M | 8.89%-192.36M | -163.80%-1.14B | -188.10%-388.8M | -265.23%-316.23M |
Net non-operating interest income (expenses) | -17.22%-2.33M | -1.91%-2.14M | -20.61%-8.44M | -5.24%-2.21M | -24.77%-2.15M | -29.55%-1.99M | -27.55%-2.1M | -69.72%-7M | -64.11%-2.1M | -110.27%-1.72M |
Non-operating interest income | --0 | -12.50%14K | -26.83%30K | --0 | -26.32%14K | --0 | -27.27%16K | 95.24%41K | --0 | 0.00%19K |
Non-operating interest expense | 17.22%2.33M | 1.80%2.15M | 20.34%8.47M | 5.24%2.21M | 24.21%2.16M | 29.55%1.99M | 26.83%2.11M | 69.85%7.04M | 64.11%2.1M | 107.77%1.74M |
Net investment income | 3,466.67%107K | -25.00%3K | 0 | 0 | ||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -99.98%31K | 124.41%31K | 0 | 0 | 0 | 113,171.55%131.16M | -2,016.67%-127K | 0 | ||
Less:Other special charges | ---- | ---- | 99.98%-31K | ---- | ---- | ---- | ---- | -113,171.55%-131.16M | 2,016.67%127K | --0 |
Other non-operating income (expenses) | -153.71%-384K | 1,053.39%4.5M | 85.82%-1.77M | 354.78%2.61M | -205.81%-4.63M | 110.12%715K | 83.74%-472K | 81.28%-12.5M | 93.09%-1.03M | 15.70%-1.51M |
Income before tax | -107.16%-207.89M | 28.21%-139.94M | 56.08%-452.68M | 80.42%-76.77M | 74.76%-80.63M | 57.20%-100.35M | -130.28%-194.93M | -104.48%-1.03B | -159.50%-392.06M | -257.72%-319.46M |
Income tax | 13.46%2.72M | 24.22%2.72M | 79.07%10.67M | 204.22%3.68M | 214.27%2.4M | -1.36%2.4M | 41.15%2.19M | -21.85%5.96M | -70.35%1.21M | -35.36%764K |
Net income | -104.97%-210.61M | 27.63%-142.66M | 55.30%-463.35M | 79.54%-80.45M | 74.07%-83.03M | 56.63%-102.75M | -128.68%-197.12M | -102.59%-1.04B | -153.46%-393.27M | -253.89%-320.23M |
Net income continuous operations | -104.98%-210.61M | 27.63%-142.66M | 55.30%-463.35M | 79.54%-80.45M | 74.07%-83.03M | 56.63%-102.75M | -128.68%-197.12M | -102.59%-1.04B | -153.46%-393.27M | -253.89%-320.22M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -104.97%-210.61M | 27.63%-142.66M | 55.30%-463.35M | 79.54%-80.45M | 74.07%-83.03M | 56.63%-102.75M | -128.68%-197.12M | -102.59%-1.04B | -153.46%-393.27M | -253.89%-320.23M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -104.97%-210.61M | 27.63%-142.66M | 55.30%-463.35M | 79.54%-80.45M | 74.07%-83.03M | 56.63%-102.75M | -128.68%-197.12M | -102.59%-1.04B | -153.46%-393.27M | -253.89%-320.23M |
Gross dividend payment | ||||||||||
Basic earnings per share | -106.19%-6 | 29.64%-4.06 | 56.65%-13.32 | 80.29%-2.29 | 75.24%-2.35 | 58.66%-2.91 | -123.64%-5.77 | -91.82%-30.73 | -147.23%-11.62 | -256.77%-9.49 |
Diluted earnings per share | -104.43%-6 | 29.64%-4.06 | 56.65%-13.32 | 80.27%-2.2927 | 75.03%-2.3697 | 58.31%-2.935 | -123.64%-5.77 | -91.82%-30.73 | -147.23%-11.62 | -247.12%-9.49 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |